Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Upleganan belongs to the class of polymyxin antibiotics and is currently in clinical trials for the treatment of multidrug-resistant bacterial infections caused by gram-negative bacteria (e.g., Pseudomonas aeruginosa infections). Upleganan aims to provide an effective treatment against multidrug-resistant bacteria.
see also:
Pseudomonas aeruginosa infections & Drugs/Treatments
…